State Street Corp Stoke Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,728,888 shares of STOK stock, worth $20.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,728,888
Previous 1,591,743 8.62%
Holding current value
$20.8 Million
Previous $21.5 Million 1.19%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$12.24 - $15.92 $1.68 Million - $2.18 Million
137,145 Added 8.62%
1,728,888 $21.2 Million
Q2 2024

Aug 14, 2024
BUY
$11.03 - $17.52 $11.2 Million - $17.7 Million
1,012,136 Added 174.62%
1,591,743 $21.5 Million
Q1 2024

May 15, 2024
BUY
$4.12 - $14.17 $148,624 - $511,168
36,074 Added 6.64%
579,607 $7.82 Million
Q4 2023

Feb 14, 2024
SELL
$3.37 - $5.4 $143,140 - $229,365
-42,475 Reduced 7.25%
543,533 $2.86 Million
Q3 2023

Nov 14, 2023
BUY
$3.78 - $11.99 $129,752 - $411,568
34,326 Added 6.22%
586,008 $2.31 Million
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $1.03 Million - $1.8 Million
130,054 Added 30.85%
551,682 $5.86 Million
Q1 2023

May 15, 2023
BUY
$7.65 - $10.38 $60,274 - $81,784
7,879 Added 1.9%
421,628 $3.51 Million
Q4 2022

Feb 14, 2023
BUY
$7.07 - $15.69 $15,971 - $35,443
2,259 Added 0.55%
413,749 $3.82 Million
Q3 2022

Nov 15, 2022
BUY
$12.56 - $22.53 $369,063 - $662,021
29,384 Added 7.69%
411,490 $5.28 Million
Q2 2022

Aug 15, 2022
SELL
$10.36 - $23.93 $5.93 Million - $13.7 Million
-571,919 Reduced 59.95%
382,106 $5.05 Million
Q1 2022

May 16, 2022
BUY
$17.19 - $26.1 $2.7 Million - $4.1 Million
157,173 Added 19.72%
954,025 $20.1 Million
Q4 2021

Feb 14, 2022
SELL
$18.11 - $30.72 $2.13 Million - $3.62 Million
-117,819 Reduced 12.88%
796,852 $19.1 Million
Q3 2021

Nov 15, 2021
BUY
$23.65 - $34.44 $232,597 - $338,717
9,835 Added 1.09%
914,671 $23.3 Million
Q2 2021

Aug 16, 2021
BUY
$30.53 - $41.09 $4.81 Million - $6.47 Million
157,548 Added 21.08%
904,836 $30.5 Million
Q1 2021

May 17, 2021
BUY
$36.08 - $69.81 $11.3 Million - $21.9 Million
313,180 Added 72.14%
747,288 $29 Million
Q4 2020

Feb 16, 2021
BUY
$33.62 - $61.93 $6.88 Million - $12.7 Million
204,696 Added 89.23%
434,108 $26.9 Million
Q3 2020

Nov 10, 2020
SELL
$22.23 - $37.48 $838,671 - $1.41 Million
-37,727 Reduced 14.12%
229,412 $7.68 Million
Q2 2020

Aug 14, 2020
SELL
$20.26 - $29.73 $549,896 - $806,931
-27,142 Reduced 9.22%
267,139 $6.37 Million
Q1 2020

May 11, 2020
BUY
$16.8 - $34.15 $4.94 Million - $10 Million
294,281 New
294,281 $6.74 Million

Others Institutions Holding STOK

# of Institutions
123
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $474M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email